New Glycan Microarray Assay from CD BioGlyco Aims to Solve Long-Standing Analytical Challenge
New York, USA, September 30, 2025 — CD BioGlyco, a biotechnology company focused on the advancement of glycobiology, reported the launch of its new Glycan Microarray Assay service, which is a solution to a long-standing problem in… Read More »New Glycan Microarray Assay from CD BioGlyco Aims to Solve Long-Standing Analytical Challenge





